American Society for Clinical Laboratory Science

Session : ASCLS902
Understanding the Role and Responsibilities of the State Society Treasurer
Conference : 77th Annual Meeting
Speaker(s) :

Download Format(s) :
MP3,SAV

$20.00

Bobbi Kochevar, MBA, CLS(NCA), Children's Hospitals and Clinics of MN

Participants will interact on what is involved with being a state-society Treasurer. This session include discussion of preparing finance summaries, budgets, and managing accounts. Information regarding checking account options for non-profit organizations and how to invest savings funds will also be presented.

Investment Return: • Discuss budget preparation for a state society • Utilize tools for effective display and tracking of accounts • Describe the role of the Treasurer and define best practices

Session : ASCLS903
Clinical Laboratory Science and Forensic Pathology
Conference : 77th Annual Meeting
Speaker(s) :

Download Format(s) :
MP3,SAV

$20.00

Nancy Jones, MD, Cook County Medical Examiner’s Office

A presentation about the contributions that Clinical Laboratory Scientists make to death investigations and the assistance that is provided by practicing forensic pathologists in their endeavors to determine the cause and manner of death.

Investment Return: • Describe the field of Forensic Pathology and cause of death determination • Summarize how common and not so common laboratory studies assist the Forensic Pathologist in determining the cause of death • Identify which laboratory test results are valid in the post mortem period and which are not

Session : ASCLS904
Transfusion Service Automation: Selection and Interfacing
Conference : 77th Annual Meeting
Speaker(s) :

Download Format(s) :
MP3,SAV

$20.00

Suzanne H. Butch, MA, CLDir(NCA), University of Michigan Hospitals and Health Centers

This session will review developing individual facility selection criteria, an overview of existing automation for the transfusion service and the special problems associated with interfacing this automation with laboratory information systems.

Investment Return: • List the instruments currently available for automated serologic testing in the transfusion service • Describe three criteria that can be used to evaluate instrument performance against facility needs • List two obstacles frequently encountered in interfacing automated serologic testing instruments to laboratory information systems

Session : ASCLS905
Molecular Comparison of Thalassemias and Hemoglobinopathies
Conference : 77th Annual Meeting
Speaker(s) :

Download Format(s) :
MP3,SAV

$20.00

Tim R. Randolph, PhD, CLS(NCA), Saint Louis University

The types of genetic mutations found in the thalassemia disorders will be compared to those found in the hemoglobinopathies. Each mutation type will be associated with the corresponding pathophysiologic effect on hemoglobin synthesis, structure and function.

Investment Return: • Describe the five categories of genetic mutations commonly found in the thalassemia disorders • Describe the single most common type of mutation found in the hemoglobinopathies • Compare and contrast the pathophysiologic effects of these mutations on hemoglobin synthesis, structure, and function

Session : ASCLS906
Regulatory & Compliance Issues in Molecular Diagnostics
Conference : 77th Annual Meeting
Speaker(s) :

Download Format(s) :
MP3,SAV

$20.00

Robyn Temple-Smolkin, PhD, CLCP(NCA), Big Sky Diagnostic Labs

Regulatory & compliance issues surrounding clinical molecular diagnostic testing can be challenging. This session seeks to discuss these issues, clarify potential areas of confusion, and share solutions to various regulatory issues. Discussion of current trends and future directions in molecular diagnostics will be included.

Investment Return: • Describe common regulatory issues facing clinical molecular diagnostic labs • Discuss solutions to meeting regulatory requirements • Discuss ongoing challenges to best laboratory practices in molecular diagnostics

Session : ASCLS908
Aspects of Hypercoagulation
Conference : 77th Annual Meeting
Speaker(s) :

Download Format(s) :
MP3,SAV

$20.00

Kathleen Finnegan, MS, MT(ASCP)SH, State University of New York at Stony Brook

Hypercoagulation is a serious and complicated group of disorders. What are the causes of the formation of unwanted blood clots? A case study format will be used to discuss thrombosis and the laboratory testing to investigate these disorders.

Investment Return: • Define hypercoagulability and thrombosis for use in protocols and manuals • Discuss causes of thrombosis and methods for the investigation of the hypercoagulable patient with laboratory staff and customers • Discuss case studies that will correlate clinical and laboratory data for the hypercoagulable state

Session : ASCLS909
The Educational Tool Box
Conference : 77th Annual Meeting
Speaker(s) :

Download Format(s) :
MP3,SAV

$20.00

Brandy Greenhill, MS, MT(ASCP), University of Texas M.D. Anderson Cancer Center

Karen McClure, PhD, MT(ASCP)SBB, University of Texas M.D. Anderson Cancer Center

There are five key factors to designing successful learning experiences: learning module design, goals, assessment tools, course activities and feedback. This session will focus on the types of enhancements which can be applied during the development of each factor that facilitate high impact and enduring learning for the participant.

Investment Return: • Define the five key factors to designing effective instruction • Describe enhancements for the five key factors • Apply enhancements to your educational activities

Session : ASCLS910
MRSA MRSA Me - Things Ain't What They Used to Be!
Conference : 77th Annual Meeting
Speaker(s) :

Download Format(s) :
MP3,SAV

$20.00

Richard B. (Tom) Thomson, Jr., PhD, D(ABMM), Evanston Hospital-Northshore University Health System

Evanston Hospital has used universal admission screening for MRSA since August 2005. Screening by relating PCR provided results in an average of 15 hours. MRSA colonized patients were isolated and decolonized with topical mupirocin. Nosocomial MRSA disease was reduced by 75%. The screening program cost approximately $750,000 per year. Reductions in nosocomial blood stream and respiratory infections alone resulted in savings greater than $750,000.

Investment Return: • Evaluate methods used to determine if a hospital has a MRSA nosocomial infection problem • Identify screening methods used to control nosocomial MRSA infection • Discuss methods used to evaluate the effectiveness of a MRSA screening program

Session : ASCLS911
Healthcare Forum
Conference : 77th Annual Meeting
Speaker(s) :

Download Format(s) :
MP3,SAV

$20.00

Moderator: Don Lavanty, JD, J.T. Rutherford and Associates

This year the symposia will focus on the FDA's post-market surveillance pilot project; legislative and regulatory efforts to oversee genetic testing; ongoing and future changes to the Medicare payments system; and the prospects for healthcare reform in 2009 and beyond.

Investment Return: • Explain ongoing FDA initiatives to identify and correct problems associated with medical devices • Identify government efforts to regulate genetic testing and what it may mean for the clinical laboratories • Use information from the Medicare payment system to ensure future readiness and compliance • Summarize legislative efforts to reform the healthcare system and the potential ramifications to the laboratory industry Joint Session with AACC

Session : ASCLS913
Platelet Antigens and Antibodies
Conference : 77th Annual Meeting
Speaker(s) :

Download Format(s) :
MP3,SAV

$20.00

Brian R. Curtis, MS, MT(ASCP)SBB, BloodCenter of Wisconsin

Platelets express a variety of immunogenic markers on the cell surface. Some are shared with other cell types (i.e. HLA), whereas others are observed to be essentially platelet-specific. This presentation will review platelet antigens and the corresponding antibodies, the assays used to detect them, and their role in immune platelet disorders.

Investment Return: • Describe the unique platelet allo antigens, the glycoproteins that carry them, antigen frequencies, and nomenclature • Describe the development and incidence of platelet-specific antibodies as they relate to your patient population • Discuss the various methods for platelet antigen/antibody testing and application of the results, in your setting

Sponsored by The Blood Center of Wisconsin